Copyright
©The Author(s) 2003.
World J Gastroenterol. Nov 15, 2003; 9(11): 2565-2569
Published online Nov 15, 2003. doi: 10.3748/wjg.v9.i11.2565
Published online Nov 15, 2003. doi: 10.3748/wjg.v9.i11.2565
Table 8 immunity change before and after therapy in MAP cases of two groups (¯x±s)
Treatment group (n = 33) | Control group (n = 37) | |||
Before therapy | After therapy | Before therapy | After therapy | |
CD3 (%) | 45.99 ± 9.75 | 52.34 ± 6.87 | 47.48 ± 10.35 | 50.18 ± 7.10 |
CD4 (%) | 36.43 ± 8.56 | 38.79 ± 7.65 | 36.01 ± 9.47 | 37.25 ± 6.92 |
CD8 (%) | 21.98 ± 6.85 | 20.46 ± 3.53 | 22.45 ± 7.11 | 21.33 ± 4.88 |
CD4/CD8 | 1.88 ± 0.64 | 1.97 ± 0.74 | 1.75 ± 0.76 | 1.85 ± 0.43 |
- Citation: Du WD, Yuan ZR, Sun J, Tang JX, Cheng AQ, Shen DM, Huang CJ, Song XH, Yu XF, Zheng SB. Therapeutic efficacy of high-dose vitamin C on acute pancreatitis and its potential mechanisms. World J Gastroenterol 2003; 9(11): 2565-2569
- URL: https://www.wjgnet.com/1007-9327/full/v9/i11/2565.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i11.2565